{"id":"W4308949853","doi":"10.1038/s41573-022-00582-5","title":"Beyond PI3Ks: targeting phosphoinositide kinases in disease","year":2022,"lang":"en","type":"review","venue":"Nature Reviews Drug Discovery","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Victoria; University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Cancer Research Society; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Michael Smith Health Research BC; National Cancer Institute; National Science Foundation","keywords":"Phosphoinositide 3-kinase; Kinase; Disease; Medicine; Biology; Cancer research; Signal transduction; Cell biology; PI3K/AKT/mTOR pathway; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008459727,0.001247368,0.001867779,0.002207549,0.000278767,0.001436905,0.001116119,0.001681939,0.006784307],"category_scores_gemma":[0.0008493209,0.0003416963,0.0007603376,0.001977739,0.0006728464,0.00191927,0.001028255,0.003374777,0.004244069],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008684811,"about_ca_system_score_gemma":0.00112049,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009949773,"about_ca_topic_score_gemma":0.00316058,"domain_scores_codex":[0.9997861,0.0000338799,0.00002176945,0.00003234458,0.00008986714,0.00003605839],"domain_scores_gemma":[0.9996603,0.0001585864,0.00003966178,0.000009791807,0.00007970311,0.00005194216],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002160101,0.00008211676,0.0000943187,0.01272621,0.0001375575,0.0001659821,0.00003491117,0.0004293703,0.002326988,0.003466477,0.07945465,0.9008654],"study_design_scores_gemma":[0.00009801607,0.000148826,0.0003388838,0.002325058,0.0001730896,0.0004733227,0.00002594177,0.0001323685,0.0003296108,0.002210204,0.9937256,0.00001908096],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007391968,0.9977146,0.000168567,0.0005180218,0.0004640996,0.000006077235,0.00003131805,0.00001660319,0.001006792],"genre_scores_gemma":[0.0005261424,0.9974717,0.0001990558,0.0005907983,0.0003259426,0.000008295217,0.00004904132,0.000002386394,0.0008266554],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006784307,"threshold_uncertainty_score":0.02269584,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03358830935975977,"score_gpt":0.3736598770361418,"score_spread":0.3400715676763821,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}